Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$8.12 - $10.63 $1.26 Million - $1.65 Million
155,267 New
155,267 $1.62 Million
Q2 2023

Jul 31, 2023

BUY
$7.2 - $9.47 $150,415 - $197,837
20,891 Added 7.08%
316,056 $2.38 Million
Q1 2023

Jun 27, 2023

BUY
$8.36 - $11.37 $2.47 Million - $3.36 Million
295,165 New
295,165 $2.61 Million
Q3 2022

Nov 03, 2022

SELL
$6.86 - $11.95 $189,466 - $330,047
-27,619 Reduced 7.31%
350,417 $2.83 Million
Q2 2022

Aug 08, 2022

BUY
$7.38 - $10.4 $2.79 Million - $3.93 Million
378,036 New
378,036 $2.84 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.